Clinical Trial

Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 14, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, positive-controlled, non-inferiority clinical study, planning to enroll 90 children with bronchiolitis caused by respiratory syncytial virus infection, to evaluate the safety and efficacy of inhaled Peginterferon α-2b injection compared to recombinant human interferon α2b in the treatment of pediatric respiratory syncytial virus bronchiolitis.
Trial Details
NCT Number NCT06827249
Lead Sponsor Children's Hospital of Soochow University
Conditions Bronchiolitis
Enrollment 90 participants
Start Date 2025-03
Primary Completion 2026-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-14